A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...
One wealth manager who pays more than $20,000 a year for membership to a longevity clinic in London was told he had some calcification in the arteries in his neck, as well as an elevated genetic risk ...
(Alliance News) - Angle PLC on Wednesday released successful results from its new dual circulating tumour DNA and circulating tumour cell DNA workflow, using Illumina Inc's sequencing technology for ...
NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform. Findings in lung cancer show that CTCs can provide additional biomarkers not found ...